| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CEP350 MYH1 AMPD1 MYH4 MYH8 EPS8L2 DST MYH13 MAP1A CENPF IFT74 SYNE1 SPTBN2 CEP57L1 DIAPH1 KIF14 MACF1 ROCK1 JAKMIP2 NOS2 ADCY8 | 5.54e-09 | 1099 | 86 | 21 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH4 MYH8 EPS8L2 DST MYH13 MAP1A SYNE1 SPTBN2 DIAPH1 MACF1 NOS2 ADCY8 | 1.31e-07 | 479 | 86 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNHD1 MYH1 MYH4 MYH8 MYH13 MCM8 VWA8 HSPA4L ABCA13 SMC6 WRN KIF14 RNF213 MACF1 | 3.44e-07 | 614 | 86 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | actin filament binding | 6.11e-06 | 227 | 86 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.20e-05 | 118 | 86 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.97e-05 | 441 | 86 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.12e-05 | 38 | 86 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | EPS15 EPS8L2 DST NLGN4X DSCAM NLGN4Y DOCK9 SPTBN2 MACF1 NOS2 GOLGA3 | 5.15e-05 | 599 | 86 | 11 | GO:0050839 |
| GeneOntologyMolecularFunction | microtubule binding | 5.47e-05 | 308 | 86 | 8 | GO:0008017 | |
| GeneOntologyMolecularFunction | tubulin binding | 9.39e-05 | 428 | 86 | 9 | GO:0015631 | |
| GeneOntologyMolecularFunction | calmodulin binding | 4.77e-04 | 230 | 86 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | cadherin binding | 6.51e-04 | 339 | 86 | 7 | GO:0045296 | |
| GeneOntologyMolecularFunction | mismatch repair complex binding | 9.83e-04 | 11 | 86 | 2 | GO:0032404 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.81e-03 | 775 | 86 | 10 | GO:0017111 | |
| GeneOntologyMolecularFunction | neurexin family protein binding | 2.12e-03 | 16 | 86 | 2 | GO:0042043 | |
| GeneOntologyMolecularFunction | chloride ion binding | 2.12e-03 | 16 | 86 | 2 | GO:0031404 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | STX19 EPS15 SNPH NLGN4X ABCA13 NLGN4Y SYNE1 SPTBN2 DIAPH1 ROCK1 | 9.02e-07 | 321 | 86 | 10 | GO:0099003 |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | 1.45e-05 | 264 | 86 | 8 | GO:0099504 | |
| GeneOntologyBiologicalProcess | male mating behavior | 3.07e-05 | 15 | 86 | 3 | GO:0060179 | |
| GeneOntologyBiologicalProcess | synaptic vesicle endocytosis | 5.08e-05 | 96 | 86 | 5 | GO:0048488 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 5.14e-05 | 3 | 86 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 6.79e-05 | 102 | 86 | 5 | GO:0140238 | |
| GeneOntologyBiologicalProcess | synaptic vesicle recycling | 1.02e-04 | 111 | 86 | 5 | GO:0036465 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 1.03e-04 | 4 | 86 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | CEP350 EVI5 DNHD1 EPS8L2 RPGRIP1L HDAC4 CCDC42 IFT74 SYNE1 ROCK1 CFAP43 | 1.05e-04 | 670 | 86 | 11 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | CEP350 EVI5 DNHD1 EPS8L2 RPGRIP1L HDAC4 CCDC42 IFT74 SYNE1 ROCK1 CFAP43 | 1.27e-04 | 685 | 86 | 11 | GO:0030031 |
| GeneOntologyBiologicalProcess | cadmium ion transport | 2.55e-04 | 6 | 86 | 2 | GO:0015691 | |
| GeneOntologyBiologicalProcess | cadmium ion transmembrane transport | 2.55e-04 | 6 | 86 | 2 | GO:0070574 | |
| GeneOntologyBiologicalProcess | cerebellum development | 2.91e-04 | 139 | 86 | 5 | GO:0021549 | |
| GeneOntologyCellularComponent | myosin complex | 1.65e-07 | 59 | 87 | 6 | GO:0016459 | |
| GeneOntologyCellularComponent | muscle myosin complex | 4.90e-07 | 16 | 87 | 4 | GO:0005859 | |
| GeneOntologyCellularComponent | myofibril | 2.04e-06 | 273 | 87 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | myosin filament | 3.31e-06 | 25 | 87 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.35e-06 | 290 | 87 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH4 MYH8 DST MYH13 HDAC4 SPTBN2 DIAPH1 MACF1 MYH16 CGNL1 ADCY8 | 4.62e-06 | 576 | 87 | 12 | GO:0015629 |
| GeneOntologyCellularComponent | myosin II complex | 5.31e-06 | 28 | 87 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | supramolecular fiber | VIM MYH1 MYH4 MYH8 SNPH RPGRIP1L DST MYH13 HDAC4 MAP1A SYNE1 SCN1A PDE4DIP CEP57L1 DIAPH1 KIF14 MACF1 | 6.12e-06 | 1179 | 87 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | VIM MYH1 MYH4 MYH8 SNPH RPGRIP1L DST MYH13 HDAC4 MAP1A SYNE1 SCN1A PDE4DIP CEP57L1 DIAPH1 KIF14 MACF1 | 6.69e-06 | 1187 | 87 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule organizing center | CEP350 EVI5 VIM EPS8L2 RPGRIP1L CCDC42 CENPF IFT74 PDE4DIP CEP57L1 WRN DIAPH1 ROCK1 BIRC6 | 2.48e-05 | 919 | 87 | 14 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | CEP350 EVI5 EPS8L2 RPGRIP1L CCDC42 CENPF IFT74 PDE4DIP CEP57L1 WRN DIAPH1 BIRC6 | 8.06e-05 | 770 | 87 | 12 | GO:0005813 |
| GeneOntologyCellularComponent | sarcomere | 8.13e-05 | 249 | 87 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 1.02e-04 | 4 | 87 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | type III intermediate filament | 2.54e-04 | 6 | 87 | 2 | GO:0045098 | |
| GeneOntologyCellularComponent | excitatory synapse | 1.04e-03 | 107 | 87 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | symmetric synapse | 1.30e-03 | 13 | 87 | 2 | GO:0032280 | |
| GeneOntologyCellularComponent | A band | 1.33e-03 | 52 | 87 | 3 | GO:0031672 | |
| GeneOntologyCellularComponent | microtubule | 1.70e-03 | 533 | 87 | 8 | GO:0005874 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 2.05e-03 | 215 | 87 | 5 | GO:0030662 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 2.09e-03 | 317 | 87 | 6 | GO:0032838 | |
| GeneOntologyCellularComponent | postsynaptic density | 2.75e-03 | 451 | 87 | 7 | GO:0014069 | |
| GeneOntologyCellularComponent | COPI-coated vesicle membrane | 2.80e-03 | 19 | 87 | 2 | GO:0030663 | |
| GeneOntologyCellularComponent | intercalated disc | 2.87e-03 | 68 | 87 | 3 | GO:0014704 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.95e-03 | 583 | 87 | 8 | GO:0097060 | |
| GeneOntologyCellularComponent | glycinergic synapse | 3.10e-03 | 20 | 87 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | spindle | 3.50e-03 | 471 | 87 | 7 | GO:0005819 | |
| GeneOntologyCellularComponent | asymmetric synapse | 3.75e-03 | 477 | 87 | 7 | GO:0032279 | |
| GeneOntologyCellularComponent | cytoplasmic region | 3.92e-03 | 360 | 87 | 6 | GO:0099568 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | VIM SNPH RPGRIP1L DST MAP1A PDE4DIP CEP57L1 DIAPH1 KIF14 MACF1 | 4.12e-03 | 899 | 87 | 10 | GO:0099513 |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 4.45e-03 | 24 | 87 | 2 | GO:0098985 | |
| Domain | Myosin_tail_1 | 1.42e-08 | 18 | 85 | 5 | PF01576 | |
| Domain | Myosin_tail | 1.42e-08 | 18 | 85 | 5 | IPR002928 | |
| Domain | Spectrin/alpha-actinin | 3.17e-07 | 32 | 85 | 5 | IPR018159 | |
| Domain | SPEC | 3.17e-07 | 32 | 85 | 5 | SM00150 | |
| Domain | Myosin_N | 5.25e-07 | 15 | 85 | 4 | PF02736 | |
| Domain | Myosin_N | 5.25e-07 | 15 | 85 | 4 | IPR004009 | |
| Domain | Myosin-like_IQ_dom | 1.47e-06 | 19 | 85 | 4 | IPR027401 | |
| Domain | - | 1.47e-06 | 19 | 85 | 4 | 4.10.270.10 | |
| Domain | Actinin_actin-bd_CS | 3.31e-06 | 23 | 85 | 4 | IPR001589 | |
| Domain | Spectrin | 3.31e-06 | 23 | 85 | 4 | PF00435 | |
| Domain | ACTININ_2 | 3.31e-06 | 23 | 85 | 4 | PS00020 | |
| Domain | ACTININ_1 | 3.31e-06 | 23 | 85 | 4 | PS00019 | |
| Domain | Spectrin_repeat | 8.70e-06 | 29 | 85 | 4 | IPR002017 | |
| Domain | IQ | 1.78e-05 | 71 | 85 | 5 | PF00612 | |
| Domain | NLGN4 | 2.05e-05 | 2 | 85 | 2 | IPR030025 | |
| Domain | Myosin_head_motor_dom | 2.62e-05 | 38 | 85 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.62e-05 | 38 | 85 | 4 | PS51456 | |
| Domain | Myosin_head | 2.62e-05 | 38 | 85 | 4 | PF00063 | |
| Domain | MYSc | 2.62e-05 | 38 | 85 | 4 | SM00242 | |
| Domain | IQ | 3.39e-05 | 81 | 85 | 5 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 5.62e-05 | 90 | 85 | 5 | IPR000048 | |
| Domain | IQ | 6.58e-05 | 93 | 85 | 5 | PS50096 | |
| Domain | Nlgn | 2.03e-04 | 5 | 85 | 2 | IPR000460 | |
| Domain | CH | 2.19e-04 | 65 | 85 | 4 | SM00033 | |
| Domain | CH | 2.91e-04 | 70 | 85 | 4 | PF00307 | |
| Domain | - | 3.03e-04 | 6 | 85 | 2 | 3.90.1290.10 | |
| Domain | GAR | 3.03e-04 | 6 | 85 | 2 | PS51460 | |
| Domain | - | 3.03e-04 | 6 | 85 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 3.03e-04 | 6 | 85 | 2 | IPR003108 | |
| Domain | GAS2 | 3.03e-04 | 6 | 85 | 2 | PF02187 | |
| Domain | GAS2 | 3.03e-04 | 6 | 85 | 2 | SM00243 | |
| Domain | - | 3.08e-04 | 71 | 85 | 4 | 1.10.418.10 | |
| Domain | CH | 3.42e-04 | 73 | 85 | 4 | PS50021 | |
| Domain | CH-domain | 3.80e-04 | 75 | 85 | 4 | IPR001715 | |
| Domain | Plectin_repeat | 4.24e-04 | 7 | 85 | 2 | IPR001101 | |
| Domain | Plectin | 4.24e-04 | 7 | 85 | 2 | PF00681 | |
| Domain | PLEC | 4.24e-04 | 7 | 85 | 2 | SM00250 | |
| Domain | P-loop_NTPase | DNHD1 MYH1 MYH4 MYH8 MYH13 MCM8 VWA8 ABCA13 SMC6 WRN KIF14 RNF213 | 4.42e-04 | 848 | 85 | 12 | IPR027417 |
| Domain | Carboxylesterase_B_CS | 1.55e-03 | 13 | 85 | 2 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 1.80e-03 | 14 | 85 | 2 | PS00941 | |
| Domain | COesterase | 1.80e-03 | 14 | 85 | 2 | PF00135 | |
| Domain | CarbesteraseB | 1.80e-03 | 14 | 85 | 2 | IPR002018 | |
| Domain | PH | 3.93e-03 | 229 | 85 | 5 | PF00169 | |
| Domain | AAA+_ATPase | 4.23e-03 | 144 | 85 | 4 | IPR003593 | |
| Domain | AAA | 4.23e-03 | 144 | 85 | 4 | SM00382 | |
| Domain | ARM-type_fold | 4.50e-03 | 339 | 85 | 6 | IPR016024 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 3.23e-05 | 43 | 60 | 4 | M41827 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 3.54e-05 | 44 | 60 | 4 | MM15678 | |
| Pubmed | CEP350 VIM EPS15 RPGRIP1L KIDINS220 DST MYH13 DSCAM SMC6 WRN RNF213 APOB CGNL1 SLC39A14 GOLGA5 SLC30A1 BIRC6 GOLGA3 | 8.88e-13 | 777 | 88 | 18 | 35844135 | |
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 5.72e-10 | 6 | 88 | 4 | 10077619 | |
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 35210422 | ||
| Pubmed | VIM EPS15 SESTD1 DST HDAC4 DSCAM CENPF SYNE1 SPTBN2 PDE4DIP DIAPH1 MACF1 ROCK1 JAKMIP2 UNC79 GOLGA3 | 2.37e-09 | 963 | 88 | 16 | 28671696 | |
| Pubmed | DOK6 SNPH MAP1A SPTBN2 DIAPH1 MROH7 KIF14 MACF1 APOB CFAP43 GOLGA3 | 5.30e-08 | 496 | 88 | 11 | 31343991 | |
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 10388558 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 1985022 | ||
| Pubmed | 1.20e-07 | 151 | 88 | 7 | 17043677 | ||
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 6196357 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 1.56e-07 | 5 | 88 | 3 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 1.56e-07 | 5 | 88 | 3 | 12919077 | |
| Pubmed | 1.80e-07 | 20 | 88 | 4 | 21689717 | ||
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 3.11e-07 | 6 | 88 | 3 | 10588881 | |
| Pubmed | AMPD1 MYH8 DST SYNE1 DOCK9 PDE4DIP MED12L MACF1 ZNF407 BIRC6 | 5.41e-07 | 497 | 88 | 10 | 23414517 | |
| Pubmed | 5.44e-07 | 7 | 88 | 3 | 16819597 | ||
| Pubmed | 8.69e-07 | 8 | 88 | 3 | 3864153 | ||
| Pubmed | 1.19e-06 | 418 | 88 | 9 | 34709266 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | EPS15 EPS8L2 KIDINS220 DST DOCK9 SPTBN2 MACF1 GOLGA5 SLC30A1 GOLGA3 | 1.72e-06 | 565 | 88 | 10 | 25468996 |
| Pubmed | 1.85e-06 | 10 | 88 | 3 | 19506036 | ||
| Pubmed | 2.28e-06 | 234 | 88 | 7 | 36243803 | ||
| Pubmed | CEP350 EPS15 RPGRIP1L DIAPH1 SUGP1 KIF14 RNF213 ROCK1 GOLGA5 SLC30A1 BIRC6 | 2.48e-06 | 733 | 88 | 11 | 34672954 | |
| Pubmed | 2.55e-06 | 11 | 88 | 3 | 8136524 | ||
| Pubmed | Advancing the understanding of autism disease mechanisms through genetics. | 4.40e-06 | 13 | 88 | 3 | 27050589 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 4.40e-06 | 13 | 88 | 3 | 8404542 | |
| Pubmed | 5.58e-06 | 14 | 88 | 3 | 27184118 | ||
| Pubmed | VIM RPGRIP1L DST ABCA13 ADAMTS20 APOB GOLGA5 CCDC136 SYNCRIP | 6.27e-06 | 513 | 88 | 9 | 25798074 | |
| Pubmed | ROCK and mDia1 antagonize in Rho-dependent Rac activation in Swiss 3T3 fibroblasts. | 6.33e-06 | 2 | 88 | 2 | 12021256 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 11002341 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 18434543 | ||
| Pubmed | ROCK and Dia have opposing effects on adherens junctions downstream of Rho. | 6.33e-06 | 2 | 88 | 2 | 11992112 | |
| Pubmed | Five skeletal myosin heavy chain genes are organized as a multigene complex in the human genome. | 6.33e-06 | 2 | 88 | 2 | 8518795 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 23183221 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 24855039 | ||
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 6.33e-06 | 2 | 88 | 2 | 37001827 | |
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 6.33e-06 | 2 | 88 | 2 | 37080762 | |
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 6.33e-06 | 2 | 88 | 2 | 9382868 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 11150240 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 29106499 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 26456829 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 6.33e-06 | 2 | 88 | 2 | 24104404 | |
| Pubmed | A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y. | 6.33e-06 | 2 | 88 | 2 | 32243781 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 9565595 | ||
| Pubmed | SYNCRIP-dependent Nox2 mRNA destabilization impairs ROS formation in M2-polarized macrophages. | 6.33e-06 | 2 | 88 | 2 | 24844655 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 22989184 | ||
| Pubmed | Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice. | 6.33e-06 | 2 | 88 | 2 | 11744674 | |
| Pubmed | 6.66e-06 | 103 | 88 | 5 | 10574462 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 7.58e-06 | 281 | 88 | 7 | 28706196 | |
| Pubmed | 8.38e-06 | 187 | 88 | 6 | 26460568 | ||
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 9.59e-06 | 111 | 88 | 5 | 22558309 | |
| Pubmed | Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis. | 1.24e-05 | 18 | 88 | 3 | 25753484 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.40e-05 | 120 | 88 | 5 | 31413325 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | KIDINS220 NLGN4X DOCK9 SPTBN2 ROCK1 APOB SLC39A14 GOLGA5 SLC30A1 | 1.43e-05 | 569 | 88 | 9 | 30639242 |
| Pubmed | 1.46e-05 | 58 | 88 | 4 | 21884692 | ||
| Pubmed | VIM MYH1 MYH4 MYH8 DST MYH13 CENPF HSPA4L SYNE1 SPTBN2 ANKRD30B MACF1 APOB SYNCRIP | 1.52e-05 | 1442 | 88 | 14 | 35575683 | |
| Pubmed | 1.58e-05 | 209 | 88 | 6 | 36779422 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.85e-05 | 588 | 88 | 9 | 38580884 | |
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 1.90e-05 | 3 | 88 | 2 | 26059207 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 36515178 | ||
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 1.90e-05 | 3 | 88 | 2 | 12399109 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 32011705 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 27880913 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 18628683 | ||
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 1.90e-05 | 3 | 88 | 2 | 21282647 | |
| Pubmed | PLEKHB2 CEP350 VIM SESTD1 DST DSCAM IFT74 SYNE1 SPTBN2 PDE4DIP CEP57L1 MACF1 GOLGA3 | 2.06e-05 | 1285 | 88 | 13 | 35914814 | |
| Pubmed | 2.06e-05 | 130 | 88 | 5 | 12421765 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | VIM RPGRIP1L DST VWA8 CENPF HSPA4L SYNE1 RNF213 SLC39A14 GOLGA5 ECSIT BIRC6 GOLGA3 SYNCRIP | 2.28e-05 | 1496 | 88 | 14 | 32877691 |
| Pubmed | 2.33e-05 | 22 | 88 | 3 | 24301466 | ||
| Pubmed | 2.90e-05 | 233 | 88 | 6 | 37704626 | ||
| Pubmed | 3.32e-05 | 486 | 88 | 8 | 20936779 | ||
| Pubmed | 3.67e-05 | 493 | 88 | 8 | 15368895 | ||
| Pubmed | Protective role of phosphorylation in turnover of glial fibrillary acidic protein in mice. | 3.79e-05 | 4 | 88 | 2 | 12177195 | |
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 3.79e-05 | 4 | 88 | 2 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 3.79e-05 | 4 | 88 | 2 | 22671294 | |
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 19265163 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 20579107 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 20357587 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 11023856 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 28743511 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 8954775 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 16077734 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 3.79e-05 | 4 | 88 | 2 | 11029314 | |
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 17292328 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 9858811 | ||
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 3.79e-05 | 4 | 88 | 2 | 18417546 | |
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 12547197 | ||
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 3.90e-05 | 26 | 88 | 3 | 34848499 | |
| Pubmed | 4.27e-05 | 76 | 88 | 4 | 27542412 | ||
| Pubmed | 4.38e-05 | 27 | 88 | 3 | 18685082 | ||
| Pubmed | Synemin acts as a regulator of signalling molecules during skeletal muscle hypertrophy. | 4.90e-05 | 28 | 88 | 3 | 25179606 | |
| Pubmed | Integrating genetic and network analysis to characterize genes related to mouse weight. | 5.45e-05 | 29 | 88 | 3 | 16934000 | |
| Pubmed | 5.50e-05 | 844 | 88 | 10 | 25963833 | ||
| Pubmed | VIM SNPH KIDINS220 DST MAP1A HSPA4L SYNE1 SPTBN2 PDE4DIP MACF1 CGNL1 GOLGA3 SYNCRIP | 6.23e-05 | 1431 | 88 | 13 | 37142655 | |
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 6.30e-05 | 5 | 88 | 2 | 30737693 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 8651505 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 15096506 | ||
| Pubmed | Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. | 6.30e-05 | 5 | 88 | 2 | 19160018 | |
| Pubmed | Gastrointestinal factors influencing zinc absorption and homeostasis. | 6.30e-05 | 5 | 88 | 2 | 21462106 | |
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 6.30e-05 | 5 | 88 | 2 | 18923512 | |
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 6.30e-05 | 5 | 88 | 2 | 10996085 | |
| Interaction | SYCE1 interactions | 7.67e-08 | 127 | 87 | 8 | int:SYCE1 | |
| Interaction | CEP63 interactions | 7.96e-08 | 179 | 87 | 9 | int:CEP63 | |
| Interaction | GOLGA1 interactions | 1.26e-06 | 183 | 87 | 8 | int:GOLGA1 | |
| Interaction | DISC1 interactions | CEP350 CWF19L2 DST MAP1A IFT74 SYNE1 PDE4DIP CEP57L1 MACF1 CCDC136 SYNCRIP | 2.34e-06 | 429 | 87 | 11 | int:DISC1 |
| Interaction | ABTB2 interactions | 4.96e-06 | 101 | 87 | 6 | int:ABTB2 | |
| Interaction | RAB35 interactions | KIDINS220 DST DOCK9 SPTBN2 DIAPH1 KIF14 MACF1 ROCK1 SLC39A14 GOLGA5 SLC30A1 GOLGA3 | 6.33e-06 | 573 | 87 | 12 | int:RAB35 |
| Interaction | APC interactions | RPGRIP1L DST HDAC4 SYNE1 SPTBN2 DIAPH1 KIF14 MACF1 CGNL1 NOS2 | 6.82e-06 | 389 | 87 | 10 | int:APC |
| Interaction | MAPRE3 interactions | 6.86e-06 | 230 | 87 | 8 | int:MAPRE3 | |
| Interaction | OCLN interactions | EPS15 KIDINS220 DST FATE1 SPTBN2 KIF14 MACF1 SLC39A14 GOLGA5 SLC30A1 GOLGA3 | 1.00e-05 | 500 | 87 | 11 | int:OCLN |
| Interaction | SYNC interactions | 1.04e-05 | 67 | 87 | 5 | int:SYNC | |
| Interaction | RSPH6A interactions | 1.36e-05 | 34 | 87 | 4 | int:RSPH6A | |
| Interaction | CDC5L interactions | VIM CWF19L2 EPS8L2 DST HDAC4 SYNE1 PDE4DIP WRN DIAPH1 MED12L KIF14 MACF1 CCDC136 SYNCRIP | 1.67e-05 | 855 | 87 | 14 | int:CDC5L |
| Interaction | PHF21A interactions | 1.72e-05 | 343 | 87 | 9 | int:PHF21A | |
| Interaction | KRT8 interactions | CEP350 VIM MYH1 RPGRIP1L HSPA4L IFT74 KIF14 BIRC6 NOS2 GOLGA3 | 2.02e-05 | 441 | 87 | 10 | int:KRT8 |
| Interaction | RHOQ interactions | KIDINS220 DST DOCK9 SPTBN2 KIF14 ROCK1 SLC39A14 GOLGA5 SLC30A1 GOLGA3 | 2.06e-05 | 442 | 87 | 10 | int:RHOQ |
| Interaction | EZR interactions | KIDINS220 DST MYH13 HDAC4 HSPA4L IFT74 KIF14 MACF1 ROCK1 SLC39A14 GOLGA3 | 2.56e-05 | 553 | 87 | 11 | int:EZR |
| Interaction | MYBPC2 interactions | 4.22e-05 | 45 | 87 | 4 | int:MYBPC2 | |
| Interaction | KALRN interactions | 5.99e-05 | 96 | 87 | 5 | int:KALRN | |
| Interaction | NDC80 interactions | 6.10e-05 | 312 | 87 | 8 | int:NDC80 | |
| Interaction | PFN1 interactions | CEP350 EPS15 KIDINS220 MAP1A IFT74 DIAPH1 KIF14 MACF1 BIRC6 GOLGA3 | 6.78e-05 | 509 | 87 | 10 | int:PFN1 |
| Interaction | BFSP1 interactions | 7.49e-05 | 52 | 87 | 4 | int:BFSP1 | |
| Interaction | MYH8 interactions | 7.49e-05 | 52 | 87 | 4 | int:MYH8 | |
| Interaction | KRT18 interactions | 8.16e-05 | 419 | 87 | 9 | int:KRT18 | |
| Interaction | PCNT interactions | 8.31e-05 | 241 | 87 | 7 | int:PCNT | |
| Interaction | DSCAM interactions | 9.78e-05 | 171 | 87 | 6 | int:DSCAM | |
| Interaction | SAR1B interactions | 1.09e-04 | 339 | 87 | 8 | int:SAR1B | |
| Interaction | SYNGR1 interactions | 1.10e-04 | 109 | 87 | 5 | int:SYNGR1 | |
| Interaction | CDH1 interactions | EPS15 EPS8L2 KIDINS220 DST DOCK9 SPTBN2 DIAPH1 MACF1 ROCK1 GOLGA5 SLC30A1 GOLGA3 | 1.11e-04 | 768 | 87 | 12 | int:CDH1 |
| Interaction | TERF2 interactions | 1.11e-04 | 340 | 87 | 8 | int:TERF2 | |
| Interaction | LZTR1 interactions | 1.19e-04 | 111 | 87 | 5 | int:LZTR1 | |
| Interaction | RHOG interactions | KIDINS220 VWA8 DOCK9 SPTBN2 DIAPH1 KIF14 MACF1 ROCK1 SLC39A14 GOLGA5 ECSIT SLC30A1 IPO11 | 1.38e-04 | 910 | 87 | 13 | int:RHOG |
| Interaction | DIRAS3 interactions | 1.40e-04 | 262 | 87 | 7 | int:DIRAS3 | |
| Interaction | ERGIC1 interactions | 1.46e-04 | 264 | 87 | 7 | int:ERGIC1 | |
| Interaction | P2RY12 interactions | 1.49e-04 | 62 | 87 | 4 | int:P2RY12 | |
| Interaction | LCK interactions | 1.73e-04 | 463 | 87 | 9 | int:LCK | |
| Interaction | NEFM interactions | 1.74e-04 | 190 | 87 | 6 | int:NEFM | |
| Interaction | TSPAN33 interactions | 1.79e-04 | 65 | 87 | 4 | int:TSPAN33 | |
| Interaction | GRIPAP1 interactions | 1.84e-04 | 192 | 87 | 6 | int:GRIPAP1 | |
| Interaction | KDM1A interactions | CEP350 VIM STX19 EPS15 RPGRIP1L DST CENPF IFT74 PDE4DIP KIF14 GOLGA5 BIRC6 GOLGA3 | 1.91e-04 | 941 | 87 | 13 | int:KDM1A |
| Interaction | SYT3 interactions | 2.11e-04 | 27 | 87 | 3 | int:SYT3 | |
| Interaction | PRKAG2 interactions | 2.14e-04 | 68 | 87 | 4 | int:PRKAG2 | |
| Interaction | RDX interactions | 2.29e-04 | 284 | 87 | 7 | int:RDX | |
| Interaction | IQGAP1 interactions | 2.29e-04 | 591 | 87 | 10 | int:IQGAP1 | |
| Interaction | ASAH2 interactions | 2.73e-04 | 6 | 87 | 2 | int:ASAH2 | |
| Interaction | CEP128 interactions | 3.00e-04 | 297 | 87 | 7 | int:CEP128 | |
| Interaction | YIPF2 interactions | 3.20e-04 | 31 | 87 | 3 | int:YIPF2 | |
| Interaction | RAC3 interactions | KIDINS220 DOCK9 SPTBN2 DIAPH1 KIF14 MACF1 ROCK1 SLC39A14 GOLGA5 SLC30A1 | 3.32e-04 | 619 | 87 | 10 | int:RAC3 |
| Interaction | KCNA3 interactions | DNHD1 VIM EPS15 KIDINS220 DST HSPA4L ABCA13 RNF213 MACF1 ROCK1 SLC30A1 SYNCRIP | 3.54e-04 | 871 | 87 | 12 | int:KCNA3 |
| Interaction | LZTS2 interactions | VIM SESTD1 CWF19L2 RPGRIP1L CEP57L1 KIF14 CGNL1 SLC39A14 BIRC6 | 3.64e-04 | 512 | 87 | 9 | int:LZTS2 |
| Interaction | TRIM37 interactions | CEP350 VIM CWF19L2 MYH4 RPGRIP1L MYH13 MAP1A DSCAM KIF14 SYNCRIP | 3.81e-04 | 630 | 87 | 10 | int:TRIM37 |
| Interaction | MEGF10 interactions | 3.86e-04 | 33 | 87 | 3 | int:MEGF10 | |
| Interaction | C11orf52 interactions | 3.96e-04 | 311 | 87 | 7 | int:C11orf52 | |
| Interaction | ATOH1 interactions | 3.99e-04 | 80 | 87 | 4 | int:ATOH1 | |
| Interaction | CIT interactions | VIM DSCAM CCDC42 VWA8 CENPF SYNE1 SPTBN2 KIF14 RNF213 MACF1 PCDHA6 TMED2 APOB CFAP43 BIRC6 SYNCRIP | 4.29e-04 | 1450 | 87 | 16 | int:CIT |
| Interaction | ELAVL3 interactions | 4.60e-04 | 35 | 87 | 3 | int:ELAVL3 | |
| Cytoband | 17p13.1 | 8.19e-05 | 118 | 88 | 4 | 17p13.1 | |
| Cytoband | 12q12 | 1.04e-04 | 47 | 88 | 3 | 12q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q12 | 2.49e-04 | 63 | 88 | 3 | chr12q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 5.55e-04 | 346 | 88 | 5 | chr17p13 | |
| Cytoband | 14q32.12 | 1.43e-03 | 29 | 88 | 2 | 14q32.12 | |
| GeneFamily | Myosin heavy chains | 6.96e-10 | 15 | 56 | 5 | 1098 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.61e-04 | 8 | 56 | 2 | 939 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.36e-04 | 206 | 56 | 5 | 682 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.70e-07 | 180 | 88 | 8 | M8239 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | DOK6 NLGN4X DSCAM PDE4DIP MED12L ROCK1 UNC79 CCDC136 ADCY8 PDZRN4 | 7.72e-06 | 506 | 88 | 10 | M39067 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CEP350 CWF19L2 KIDINS220 HSPA4L IFT74 SMC6 WRN KIF14 ZNF407 JAKMIP2 PUS7L | 1.24e-05 | 656 | 88 | 11 | M18979 |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 1.26e-05 | 152 | 88 | 6 | M39243 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 2.57e-05 | 103 | 88 | 5 | M1170 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CEP350 EVI5 EPS15 KIDINS220 DST HDAC4 CENPF DOCK9 WRN KIF14 MACF1 ROCK1 | 2.87e-05 | 856 | 88 | 12 | M4500 |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 3.68e-05 | 111 | 88 | 5 | MM1111 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 4.00e-05 | 20 | 88 | 3 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 4.66e-05 | 21 | 88 | 3 | MM1102 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.32e-08 | 181 | 88 | 7 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.37e-06 | 176 | 88 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.41e-06 | 177 | 88 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.83e-06 | 185 | 88 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.83e-06 | 185 | 88 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.88e-06 | 186 | 88 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.88e-06 | 186 | 88 | 6 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 2.00e-06 | 188 | 88 | 6 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-06 | 189 | 88 | 6 | fa1ff8b7fa53f3148d9117d6e598097f03af5eb2 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-06 | 189 | 88 | 6 | 565063f9e3dd79164321f8a394bd12c176baf202 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-06 | 189 | 88 | 6 | 497be236848ebf5ad75d1f0c71e6261f5d3521da | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 2.40e-06 | 194 | 88 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 4.42e-06 | 122 | 88 | 5 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.99e-06 | 62 | 88 | 4 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.99e-06 | 62 | 88 | 4 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.78e-06 | 137 | 88 | 5 | 0aa4e14b32da0cda677cc0ed6ae470f6ecd77bea | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.51e-05 | 157 | 88 | 5 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.86e-05 | 164 | 88 | 5 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-05 | 164 | 88 | 5 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 2.15e-05 | 169 | 88 | 5 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.21e-05 | 170 | 88 | 5 | 8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.27e-05 | 171 | 88 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.06e-05 | 182 | 88 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 184 | 88 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 184 | 88 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 184 | 88 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-05 | 185 | 88 | 5 | fa94c4a1660967f211ba095606cd0aa37d38e17a | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.31e-05 | 185 | 88 | 5 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | E15.5-Epithelial-airway_epithelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.40e-05 | 186 | 88 | 5 | bb2c7af3b1d8478c49a8626dbfd6c92c5e7adc4a | |
| ToppCell | E15.5-Epithelial-airway_epithelial_cell-club_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.40e-05 | 186 | 88 | 5 | 86c809b99088d3d6c8f87785797c4beefdcddbe7 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.48e-05 | 187 | 88 | 5 | f777dd5eb5ccd554ebe1ed60a738b5dd45e18bb9 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.48e-05 | 187 | 88 | 5 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.48e-05 | 187 | 88 | 5 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| ToppCell | multiciliated|World / shred by cell class for bronchial biopsy | 3.57e-05 | 188 | 88 | 5 | 6833c1f0f265ef5448fa65033550ed7efc2f8d7b | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.57e-05 | 188 | 88 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 3.66e-05 | 189 | 88 | 5 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.76e-05 | 190 | 88 | 5 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.76e-05 | 190 | 88 | 5 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 191 | 88 | 5 | 297bc79adc5fef211497819b4861b52cd26ac754 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 191 | 88 | 5 | e1ec165ba6578cefd88895e7e183190e79f733a4 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.95e-05 | 192 | 88 | 5 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | Ciliated-cil-3|World / Class top | 3.95e-05 | 192 | 88 | 5 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.05e-05 | 193 | 88 | 5 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.05e-05 | 193 | 88 | 5 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.05e-05 | 193 | 88 | 5 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 4.15e-05 | 194 | 88 | 5 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 4.15e-05 | 194 | 88 | 5 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 4.15e-05 | 194 | 88 | 5 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.15e-05 | 194 | 88 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.15e-05 | 194 | 88 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.25e-05 | 195 | 88 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 4.25e-05 | 195 | 88 | 5 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.25e-05 | 195 | 88 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.36e-05 | 196 | 88 | 5 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.36e-05 | 196 | 88 | 5 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 196 | 88 | 5 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.36e-05 | 196 | 88 | 5 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.36e-05 | 196 | 88 | 5 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.36e-05 | 196 | 88 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.36e-05 | 196 | 88 | 5 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.46e-05 | 197 | 88 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.46e-05 | 197 | 88 | 5 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.46e-05 | 197 | 88 | 5 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.46e-05 | 197 | 88 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.46e-05 | 197 | 88 | 5 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.46e-05 | 197 | 88 | 5 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | mild-pDC|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.46e-05 | 197 | 88 | 5 | 15230a54fa5903dd728de1a0ad633bd2d2c7a04d | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.46e-05 | 197 | 88 | 5 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.57e-05 | 198 | 88 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.57e-05 | 198 | 88 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.68e-05 | 199 | 88 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.68e-05 | 199 | 88 | 5 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | (10)_Ciliated|World / shred by cell type by condition | 4.79e-05 | 200 | 88 | 5 | 1b6a8025bd2746b626040058c122b1be3ab2fa61 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-05 | 200 | 88 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-05 | 200 | 88 | 5 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 4.79e-05 | 200 | 88 | 5 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.79e-05 | 200 | 88 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-05 | 200 | 88 | 5 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 4.79e-05 | 200 | 88 | 5 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 4.79e-05 | 200 | 88 | 5 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.79e-05 | 200 | 88 | 5 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-05 | 200 | 88 | 5 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Control-Lymphoid_T/NK-NK_activated|Control / Disease group, lineage and cell class | 9.14e-05 | 119 | 88 | 4 | a258d91ac90d4174b6f203d7f96ba6e57c6003e7 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 9.75e-05 | 121 | 88 | 4 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.11e-04 | 125 | 88 | 4 | d05556ea185c15815a4f8643f1c01185badbeece | |
| ToppCell | -IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.21e-04 | 128 | 88 | 4 | dab10774bc0532a1664fd8ac2b54cffab01be55a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 136 | 88 | 4 | 82b1d6d839c0d0c68e0960549f688138479defcc | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.90e-04 | 144 | 88 | 4 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | droplet-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 145 | 88 | 4 | f142b86d4da5b71c189da46cbc4beebdc387ffee | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.40e-05 | 49 | 48 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.93e-05 | 50 | 48 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.27e-08 | 10 | 84 | 4 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.27e-08 | 10 | 84 | 4 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.27e-08 | 10 | 84 | 4 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.27e-08 | 10 | 84 | 4 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.27e-08 | 10 | 84 | 4 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.27e-08 | 10 | 84 | 4 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.27e-08 | 10 | 84 | 4 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.27e-08 | 10 | 84 | 4 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 2.97e-08 | 12 | 84 | 4 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.97e-08 | 12 | 84 | 4 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 4.28e-08 | 13 | 84 | 4 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 8.14e-08 | 15 | 84 | 4 | DOID:0050646 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 3.37e-06 | 80 | 84 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 1.08e-05 | 48 | 84 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | AMPD1 NLGN4X ABCA13 SYNE1 SPTBN2 WRN APOB JAKMIP2 ADCY8 PDZRN4 | 3.09e-05 | 702 | 84 | 10 | C0009402 |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 4.79e-05 | 4 | 84 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 5.13e-05 | 71 | 84 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.55e-05 | 152 | 84 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cerebellar ataxia (is_implicated_in) | 7.96e-05 | 5 | 84 | 2 | DOID:0050753 (is_implicated_in) | |
| Disease | Silicosis | 2.85e-04 | 9 | 84 | 2 | C0037116 | |
| Disease | protein CREG1 measurement | 2.85e-04 | 9 | 84 | 2 | EFO_0801937 | |
| Disease | Intellectual Disability | 2.90e-04 | 447 | 84 | 7 | C3714756 | |
| Disease | migraine disorder | 5.53e-04 | 357 | 84 | 6 | MONDO_0005277 | |
| Disease | Manganese Poisoning | 7.13e-04 | 14 | 84 | 2 | C0677050 | |
| Disease | bipolar disorder, response to lithium ion | 7.13e-04 | 14 | 84 | 2 | GO_0010226, MONDO_0004985 | |
| Disease | serum IgG glycosylation measurement | 7.37e-04 | 523 | 84 | 7 | EFO_0005193 | |
| Disease | low density lipoprotein triglyceride measurement | 8.21e-04 | 15 | 84 | 2 | EFO_0009946 | |
| Disease | amenorrhea, response to antineoplastic agent | 8.21e-04 | 15 | 84 | 2 | EFO_0010269, GO_0097327 | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 1.11e-03 | 71 | 84 | 3 | EFO_0004735, EFO_0007965 | |
| Disease | nevus count | 1.19e-03 | 18 | 84 | 2 | EFO_0004632 | |
| Disease | Meckel syndrome type 1 | 1.19e-03 | 18 | 84 | 2 | C3714506 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 1.19e-03 | 18 | 84 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | metabolonic lactone sulfate measurement | 1.33e-03 | 19 | 84 | 2 | EFO_0800659 | |
| Disease | empathy measurement | 1.43e-03 | 170 | 84 | 4 | EFO_0009183 | |
| Disease | anti-Mullerian hormone measurement | 1.47e-03 | 20 | 84 | 2 | EFO_0004769 | |
| Disease | systemising measurement | 1.62e-03 | 21 | 84 | 2 | EFO_0010221 | |
| Disease | Retinal Diseases | 2.68e-03 | 27 | 84 | 2 | C0035309 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EINEMKELREHNENM | 936 | P40145 | |
| EMLLMEKTQNHEQDG | 111 | A1L162 | |
| ILNMMEENDKLENIA | 821 | Q8NDM7 | |
| PEMKMQRHLNEKNEE | 1336 | Q9BXX2 | |
| DQHLAMMVALQEDIQ | 1911 | Q9NR09 | |
| KEIQDLAEEIHGMMD | 116 | Q86UQ4 | |
| FQVHQMLNEMDELKE | 271 | P23109 | |
| GLNMEILEEQMLHEI | 3751 | Q96M86 | |
| MRHDLMQSAQEGQEK | 181 | Q96M95 | |
| FEQMLLDMNLNEEKQ | 96 | O60610 | |
| MNEDLNVMKERVLGH | 221 | P59510 | |
| KNMDGMLVVEAVHNL | 1051 | Q68CQ1 | |
| LNLEMLEEEHNEAMQ | 506 | Q6ZMN7 | |
| MDEQELENMLKPFGH | 151 | Q6XE24 | |
| IMMGKAENQDLNEDH | 781 | Q9UN73 | |
| QEEMLEMAQKGVLHA | 1026 | P35228 | |
| ELQKAGIMFQMDNHL | 786 | Q15058 | |
| NIDELKKEMNMNFGD | 1251 | Q9ULH0 | |
| EGAEAALHQKMMELE | 671 | Q96AA8 | |
| QEMLAMKHQQELLEH | 116 | P56524 | |
| NLGKEEMGHLMQAED | 1231 | P78559 | |
| QDDIKARQMMHEALQ | 1506 | Q86YW9 | |
| DKMGNQHQALLEAME | 521 | Q9UJA3 | |
| LMANGDELNMQLKEQ | 306 | Q68CZ1 | |
| RVDILENQVMDNHME | 96 | P46439 | |
| QKEMDQHFGMVELLN | 5001 | Q03001 | |
| EMQREEIQKLMGQIH | 476 | Q8TBA6 | |
| MGQIHQLRSELQDME | 486 | Q8TBA6 | |
| NEMAHKFNQEMDQLL | 811 | Q9UI26 | |
| KAMEEMNGKDLEGEN | 386 | O60506 | |
| MEGDLNEMEIQLNHA | 1621 | P13535 | |
| MGNMELAEQLKVQLE | 506 | Q2TBE0 | |
| ELMQLDMEGMLQHFQ | 366 | O60447 | |
| KMEGDLNEMEIQLNH | 1621 | P12882 | |
| EILDGMDQSHRKEMQ | 201 | Q6ZMK1 | |
| KQEMDSLQRQMEEHA | 1436 | Q08378 | |
| GNKDELMQHMDEVND | 581 | Q9H6S3 | |
| NEGLMDEKLLHNVLM | 2356 | Q9UPN3 | |
| QQIEMEKLNHQGELM | 6166 | Q9UPN3 | |
| NEEIMSLQMKQLEHD | 726 | Q8NFZ3 | |
| TKDDKHEQDMVNGIM | 741 | P04114 | |
| RQLDMDLEEHQGEMN | 341 | Q96LB3 | |
| MKEHENDPEMLVDLQ | 1586 | Q9BZ29 | |
| GEIEENLMKAEQMHQ | 861 | P49454 | |
| AEQHERLMLEMEQKA | 231 | Q6PKX4 | |
| KLQRELEEQMDMNEH | 1231 | Q0VF96 | |
| LEEQMDMNEHLQGQL | 1236 | Q0VF96 | |
| EEMLKERQSDQDMNH | 2326 | Q5VT06 | |
| QSHGLEGLNKEIMME | 511 | Q9NWL6 | |
| QDELDQMSMEHQELL | 331 | Q8IYX8 | |
| LMEMKDLENHNSQLN | 496 | P42566 | |
| AMNMNVQHEREDKNI | 1976 | Q8NDH2 | |
| EKVKEHQESMDMNNP | 246 | P11712 | |
| GENQEHLVIAEMMEL | 26 | Q969F0 | |
| HVGMELQLKQELAML | 266 | Q6ZMJ2 | |
| EGVMEKLQNGDLDHM | 271 | Q15043 | |
| NEEIMSLQMKQLEHD | 726 | Q8N0W4 | |
| EQMENHGVMPNKETE | 166 | Q9BQ95 | |
| NHENLIMDHMVKSDG | 366 | O60469 | |
| QNIEDKVHMPMDCIN | 41 | Q96CS7 | |
| QQLAHHKAMMEEIAG | 3961 | Q8NF91 | |
| AEHQALMDEILMLQD | 6001 | Q8NF91 | |
| HTDQIGLALLKNEMM | 441 | Q9H0K6 | |
| KMEGDLNEMEIQLNH | 1621 | Q9Y623 | |
| MEMLKHLSPNDNEND | 446 | Q14191 | |
| LHSMEVAQNGMAKED | 181 | O15079 | |
| DNEMNNLQIAVDRMH | 1006 | P35498 | |
| NKENVDHIQGVMEDM | 461 | Q86VW0 | |
| DHIQGVMEDMQLRKQ | 466 | Q86VW0 | |
| QQLRDAEEQMHGMKN | 301 | Q96JN2 | |
| GKMNMNILHQEELIA | 26 | Q8IWZ8 | |
| NIPLVMNNERHKGEM | 3676 | Q63HN8 | |
| EQELHMMGQEKAKDE | 1606 | O15020 | |
| MDKMQVDQEEGHQKC | 526 | O95757 | |
| EMSEEDVNDMLHQGK | 176 | Q8N4C7 | |
| QDEIQNMKEEMARHL | 366 | P08670 | |
| KMEGDLNEMEIQLGH | 1621 | Q9UKX3 | |
| EEHMEQQKENMEHLK | 756 | Q96SB8 | |
| DLNMEQGMAEHLKDV | 91 | Q9BTX3 | |
| METDLNEMEIQLDHA | 781 | Q9H6N6 | |
| EEQLHNEMQLKDEME | 436 | Q13464 | |
| METEAHQNKLEEMIN | 121 | Q15363 | |
| DLLELMMLQNAQMHQ | 46 | P0C7W0 | |
| DENQTHEMIMERLAG | 121 | Q8N859 | |
| AQIIMQEAQGEHMDL | 2121 | Q9C0G0 | |
| VKEMEQGHSDLEKMQ | 681 | Q502W6 | |
| DHMELEEDRAGQLNM | 231 | Q9Y6M5 | |
| DNIQHVIVMEDMLKD | 756 | A3KMH1 | |
| RHQMKGEDAQPQEMA | 51 | Q9NSD4 | |
| EMQQQMIGEEPLDHL | 1001 | Q6ZQQ6 | |
| EEAIMQPLDHKNLDM | 81 | Q03393 | |
| EQQVDMHDMLLEELA | 116 | Q6P9G9 | |
| QMELQDDGITMGLEH | 811 | Q9P2D8 | |
| GQNDTMAKLREMLHQ | 306 | Q5VU43 |